Fluorine F18-EF5 and Fludeoxyglucose F18 Positron Emission Tomography in Assessing Hypoxia and Glycolysis in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

NCT01017133 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

RADIATION: fludeoxyglucose F 18
RADIATION: Fluorine F 18 EF5
PROCEDURE: Positron emission tomography

Sponsor

Abramson Cancer Center at Penn Medicine